Phospho-DOK1 (Tyr398) Antibody

What is DOK1 and why is the phosphorylation at Tyr398 significant?

DOK1 (Downstream of tyrosine kinase 1, also known as p62DOK) functions as a scaffold protein that forms a platform for the assembly of multiprotein signaling complexes. It is a critical component in signal transduction pathways downstream of receptor tyrosine kinases. DOK1 participates in various cellular processes including cell proliferation, differentiation, and apoptosis .

The phosphorylation of DOK1 at tyrosine 398 is particularly significant because it represents a key regulatory modification that occurs during fibroblast growth factor receptor (FGFR) signaling. This specific phosphorylation site has been identified as Src Family Kinase (SFK)-dependent, making it a crucial marker for studying SFK-mediated signaling cascades in both normal cellular processes and pathological conditions .

What applications is Phospho-DOK1 (Tyr398) Antibody validated for?

Phospho-DOK1 (Tyr398) Antibody has been validated for multiple research applications:

The antibody specifically detects endogenous levels of p62Dok only when phosphorylated at tyrosine 398, making it a highly specific tool for monitoring this post-translational modification in experimental systems .

What positive controls are recommended for validating Phospho-DOK1 (Tyr398) Antibody experiments?

For Western blot applications, K562 cells (particularly when treated with H2O2) serve as an effective positive control as they express detectable levels of phosphorylated DOK1 at Tyr398. For immunohistochemistry applications, human breast carcinoma tissue sections are recommended as positive controls . When implementing these controls, researchers should include both phosphopeptide-blocked and non-blocked antibody conditions to confirm specificity of the immunoreactivity.

What are the optimal conditions for using Phospho-DOK1 (Tyr398) Antibody in Western blotting?

For optimal Western blot results with Phospho-DOK1 (Tyr398) Antibody, the following methodological approach is recommended:

• Sample preparation: Lyse cells in buffer containing phosphatase inhibitors to preserve phosphorylation status

• Protein separation: Use 10-12% SDS-PAGE gels for optimal resolution

• Transfer conditions: Semi-dry or wet transfer at constant current (1 mA/cm²)

• Blocking: 5% BSA in TBST (preferred over milk which contains phosphatases)

• Primary antibody incubation: 1:500-1:1000 dilution overnight at 4°C

• Secondary antibody: Anti-rabbit HRP-conjugated (1:5000)

• Detection: Enhanced chemiluminescence

• Controls: Include lysates from cells treated with tyrosine phosphatase inhibitors (such as H2O2) as positive controls

This approach maximizes detection specificity while minimizing background signal. For verification of phospho-specificity, parallel blots using phosphatase-treated samples can establish that the antibody recognition is phosphorylation-dependent.

How should researchers design experiments to study SFK-dependent phosphorylation of DOK1 at Tyr398?

To effectively study SFK-dependent phosphorylation of DOK1 at Tyr398, researchers should consider the following experimental design:

• SILAC (Stable Isotope Labeling with Amino acids in Cell culture) approach:

  • Light media: Control cells

  • Heavy media: Experimental condition cells

  • Compare samples with and without SFK inhibitor treatment

• Pharmacological inhibition:

  • Use selective SFK inhibitors (e.g., PP2, dasatinib)

  • Include appropriate controls (vehicle, inactive analogs)

  • Monitor effects on DOK1 phosphorylation via Western blot

• Stimulation conditions:

  • FGF2 stimulation (typically 20 ng/mL for 15-30 minutes)

  • Pre-treatment with SFK inhibitors before stimulation

  • Time-course analysis to determine phosphorylation kinetics

• Verification approaches:

  • Immunoprecipitation of DOK1 followed by phosphotyrosine blotting

  • Phospho-specific antibody detection of Tyr398

  • Mass spectrometry validation of phosphorylation site

This comprehensive approach enables quantitative assessment of SFK dependency for DOK1 Tyr398 phosphorylation in response to various stimuli.

How can researchers distinguish between different phosphorylation sites on DOK1 when multiple sites are phosphorylated simultaneously?

Distinguishing between multiple phosphorylation sites on DOK1 requires sophisticated analytical approaches:

• Site-specific antibodies: Utilize multiple phospho-specific antibodies targeting different sites (including pTyr398, pTyr295) in parallel analyses

• Mass spectrometry approaches:

  • Phosphopeptide enrichment using TiO₂ or phosphotyrosine immunoprecipitation

  • Multiple Reaction Monitoring (MRM) for targeted quantification of specific phosphopeptides

  • Parallel Reaction Monitoring (PRM) for improved selectivity

• Mutational analysis:

  • Generate point mutations at individual phosphorylation sites

  • Assess functional consequences of each mutation

  • Create phosphomimetic variants (e.g., Y→E substitutions)

• Sequential immunoprecipitation:

  • First IP with one phospho-specific antibody

  • Analyze flow-through with second phospho-specific antibody

  • Determine co-occurrence patterns of different phosphorylation events

Research has identified at least 9 SFK-dependent phosphorylation sites on DOK1, with 6 previously unknown to be SFK-dependent. This highlights the complexity of DOK1 regulation and the need for sophisticated analytical approaches.

What are the critical considerations when performing quantitative analysis of DOK1 Tyr398 phosphorylation?

Quantitative analysis of DOK1 Tyr398 phosphorylation demands careful technical considerations:

• Normalization strategies:

  • Total DOK1 protein expression must be quantified in parallel

  • Calculate phospho-DOK1/total DOK1 ratio for accurate comparisons

  • Use housekeeping proteins (GAPDH, β-actin) as loading controls

• Statistical validation:

  • Establish significance thresholds (typically p<0.05)

  • For SILAC experiments, ratios <0.616 or >1.624 typically indicate significant changes

  • Calculate variability percentage using standard deviation of natural logarithms of SILAC ratios, multiplied by 100

• Phosphatase controls:

  • Include λ-phosphatase treated samples to confirm antibody phospho-specificity

  • Use phosphatase inhibitors in all sample preparation buffers

  • Monitor for artifactual dephosphorylation during sample handling

• Dynamic range considerations:

  • Establish linear detection range for phospho-signal

  • Use appropriate exposure times to avoid signal saturation

  • Consider multiple antibody dilutions to optimize signal-to-noise ratio

These methodological considerations ensure reliable quantification of phosphorylation dynamics in experimental systems.

How does phosphorylation of DOK1 at Tyr398 regulate its interaction with binding partners?

Phosphorylation of DOK1 at Tyr398 creates a specific recognition motif that significantly influences its protein-protein interaction network:

• SH2 domain interactions: The phosphorylated Tyr398 residue (within the sequence E-G-Y(p)-E-L) creates a binding site for proteins containing SH2 (Src Homology 2) domains.

• Identified binding partners: Research has identified 18 SFK-dependent DOK1 interactions that are mediated by phosphorylation events. The phosphorylation status at Tyr398 directly affects binding affinity and specificity for these interaction partners .

• Regulatory mechanism: This phosphorylation functions as a molecular switch that can activate or inhibit downstream signaling pathways by recruiting specific effector proteins, thereby functioning as a dynamic regulator of signal transduction.

• Temporal dynamics: The phosphorylation of Tyr398 exhibits specific kinetics following receptor tyrosine kinase activation, with temporal patterns that correlate with recruitment of distinct binding partners during different phases of signaling.

These phosphorylation-dependent interactions are critical for understanding how DOK1 functions as a scaffolding protein in various cellular processes and signaling pathways.

What is the relationship between DOK1 Tyr398 phosphorylation and FGFR signaling pathways?

The relationship between DOK1 Tyr398 phosphorylation and FGFR signaling represents a sophisticated regulatory mechanism:

• Signaling cascade initiation:

  • FGFR activation leads to recruitment and activation of SFKs

  • Activated SFKs phosphorylate DOK1 at multiple sites, including Tyr398

  • Phosphorylated DOK1 scaffolds multiple signaling proteins

• Feedback regulation:

  • DOK1 phosphorylation can both promote and attenuate FGFR signaling

  • Phosphorylated DOK1 recruits both positive and negative regulators

  • The temporal pattern of phosphorylation determines net signaling output

• Pathway integration:

  • DOK1 serves as an integration point between FGFR and other pathways

  • Phosphorylation at Tyr398 may represent cross-talk with other receptor systems

  • The specific phosphorylation pattern encodes signaling information

Research using SILAC combined with chemical inhibition of SFK activity has identified that DOK1 phosphorylation at Tyr398 is a key event in FGFR signaling pathways, with significant implications for understanding cellular responses to FGF stimulation.

How can researchers troubleshoot non-specific binding when using Phospho-DOK1 (Tyr398) Antibody?

When encountering non-specific binding with Phospho-DOK1 (Tyr398) Antibody, researchers should implement the following troubleshooting strategies:

• Antibody validation controls:

  • Utilize blocking peptides specific to the phosphorylated epitope

  • Include phosphatase-treated samples as negative controls

  • Test antibody on lysates from DOK1 knockout or knockdown cells

• Optimization of immunoblotting conditions:

  • Use 5% BSA instead of milk for blocking (milk contains phosphatases)

  • Increase washing duration and detergent concentration

  • Titrate primary antibody concentration (test 1:500 to 1:2000 dilutions)

  • Reduce secondary antibody concentration if background is high

• Sample preparation refinements:

  • Ensure complete cell lysis with phosphatase inhibitors

  • Pre-clear lysates with protein A/G beads

  • Perform immunoprecipitation before Western blotting for enrichment

  • Consider phosphotyrosine enrichment before analysis

Validation experiments demonstrate that proper controls can differentiate between specific and non-specific signals, as evidenced by paired Western blot analysis with and without blocking peptide pre-incubation.

What are the most reliable methods to validate phospho-specificity of the antibody?

Validating the phospho-specificity of Phospho-DOK1 (Tyr398) Antibody requires multiple complementary approaches:

• Phosphatase treatment:

  • Treat duplicate samples with λ-phosphatase

  • Compare immunoreactivity between treated and untreated samples

  • Loss of signal confirms phospho-specificity

• Blocking peptide competition:

  • Pre-incubate antibody with phospho-peptide used as immunogen

  • Compare signal between blocked and non-blocked antibody

  • Specific reduction in signal confirms epitope specificity

• Mutational validation:

  • Express wild-type DOK1 and Y398F mutant versions

  • Stimulate cells to induce phosphorylation

  • Absence of signal in Y398F mutant confirms site-specificity

• Stimulus-response correlation:

  • Monitor phosphorylation after FGF stimulation with/without SFK inhibitors

  • Expected temporal pattern of phosphorylation supports specificity

  • Correlation with known regulatory events provides biological validation

Immunohistochemical analysis has demonstrated the specificity of this approach, where human breast carcinoma tissue shows positive staining with the Phospho-DOK1 (Tyr398) Antibody that is eliminated when the antibody is pre-incubated with the blocking peptide.

How can Phospho-DOK1 (Tyr398) Antibody be used to investigate signaling networks in cancer cells?

Phospho-DOK1 (Tyr398) Antibody offers sophisticated applications for investigating cancer cell signaling networks:

• Receptor tyrosine kinase profiling:

  • Monitor DOK1 Tyr398 phosphorylation across cancer cell panels

  • Correlate phosphorylation with activation of various RTKs

  • Identify cancer-specific signaling dependencies

• Therapeutic response assessment:

  • Evaluate changes in DOK1 phosphorylation after kinase inhibitor treatment

  • Use as a biomarker for target engagement in drug development

  • Monitor for compensatory phosphorylation events indicating resistance

• Multi-parameter phospho-profiling:

  • Combine with other phospho-specific antibodies for network analysis

  • Implement reverse-phase protein arrays for high-throughput screening

  • Create kinase-substrate relationship maps in different cancer contexts

• In vivo applications:

  • Use in patient-derived xenograft models to assess pathway activation

  • Apply to tissue microarrays for clinical correlation studies

  • Potential diagnostic application in personalized oncology approaches

The significance of DOK1 phosphorylation in cancer contexts is highlighted by the use of human breast carcinoma as a positive control for immunohistochemistry applications, suggesting relevant phosphorylation patterns in this disease context.

What emerging technologies can enhance the study of DOK1 phosphorylation dynamics?

Several cutting-edge technologies are enhancing the study of DOK1 phosphorylation dynamics:

• Proximity ligation assays (PLA):

  • Enables in situ visualization of phosphorylated DOK1 interacting with partner proteins

  • Provides single-molecule resolution of protein interactions

  • Allows quantification of interaction frequencies in intact cells

• Phospho-proteomic mass spectrometry:

  • Data-independent acquisition (DIA) for comprehensive phosphopeptide profiling

  • Tandem mass tagging (TMT) for multiplexed quantitative analysis

  • Absolute quantification using synthetic phosphopeptide standards

  • Ion mobility separation for improved phosphosite discrimination

• Live-cell phosphorylation sensors:

  • FRET-based biosensors specific for DOK1 Tyr398 phosphorylation

  • Split fluorescent protein complementation systems

  • Phospho-specific nanobodies for real-time monitoring

• Spatial proteomics approaches:

  • Imaging mass cytometry to visualize phosphorylation in tissue context

  • Digital spatial profiling for region-specific phosphorylation analysis

  • Correlation with subcellular localization data

These advanced technologies provide unprecedented insights into the spatiotemporal regulation of DOK1 phosphorylation and its role in coordinating multiprotein signaling complexes in diverse cellular contexts.